Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report

Meera B. Ganesh*, Briana S. Kaplunov, Matthew S. Lee, Mark A. Assmus, Ashley E. Ross, Joy Coleman, Amy E. Krambeck

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Herein, we describe a case of a patient diagnosed with prostate cancer (PCa) who presented with lower urinary tract symptoms (LUTS) and elevated Prostate Specific Antigen (PSA). He underwent Holmium Laser Enucleation of the Prostate (HoLEP) for his severe LUTS with concurrent placement of SpaceOAR gel and gold fiducials in preparation for radiation therapy (RT). After a successful operation, the patient underwent same-day discharge and catheter removal. He regained continence at 2 weeks and started RT at 9 weeks post-HoLEP. We present that concurrent placement of fiducials and SpaceOAR during HoLEP appears to be feasible, well tolerated and effective for PCa patients who elect RT.

Original languageEnglish (US)
JournalTherapeutic Advances in Urology
Volume14
DOIs
StatePublished - Jan 2022

Keywords

  • HoLEP and prostate cancer
  • SpaceOAR and HoLEP
  • gold fiducials and HoLEP

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report'. Together they form a unique fingerprint.

Cite this